Chronic Multisymptom Illness CMI

Publication Date: May 1, 2021
Last Updated: March 14, 2022

Recommendations

Treatment of CMI

a. Pharmacotherapy

1. We recommend against the long-term use of opioid medications for the management of chronic pain in patients with CMI. (Strong against)
315659
2. We recommend against offering mifepristone for patients with CMI. (Strong against)
315659

b. Behavioral Health

3. We suggest offering cognitive behavioral therapy for CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. (Weak for)
315659
4. We suggest offering mindfulness-based therapies for patients with CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. (Weak for)
315659
5. There is insufficient evidence to recommend for or against the use of biofeedback modalities in patients with CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. ()
(Neither for nor against)
315659

c. Complementary and Integrative Health

6. There is insufficient evidence to recommend for or against the use of manual musculoskeletal therapies for patients with CMI and symptoms consistent with fibromyalgia, irritable bowel syndrome, or myalgic encephalomyelitis/chronic fatigue syndrome. ()
(Neither for nor against)
315659

Overview

Title

Chronic Multisymptom Illness CMI

Authoring Organization

Veterans Health Administration / Department of Defense